Abstract
Platelet-activating factor (PAF) is a group of phosphocholines with various biological effects, which are mediated by the PAF receptor (PAF-R). Our previous studies have demonstrated that ultraviolet B radiation (UVB) is a potent stimulus for PAF production, and that the presence of the PAF-R on epithelial cells results in an augmentation of UVB-induced apoptosis. Inasmuch as PAF-R activation results in numerous signal transduction pathways, the present study was designed to characterize the signal transduction pathway responsible for PAF-R-mediated enhanced UVB-induced cytotoxicity. Using a model system of PAF-R-negative and -positive epithelioid KB cells, we demonstrate that inhibitors of p38 MAP kinase block the augmentation of UVB-mediated apoptosis seen in PAF-R-positive KB cells. In contrast, pharmacological and/or molecular inhibition of other pathways linked to PAF-R activation including ERK MAP kinase and NFκB do not affect PAF-R-mediated cytotoxicity. This study demonstrates the important role that p38 MAP kinase plays in PAF-R-mediated augmentation of UVB cytotoxicity.
References
Ahn KS, Hahn BS, Kwack K, Lee EB, Kim YS (2006) Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes Eur J Pharmacol 537:1–11
Barber L, Spandau D, Rathman S, Murphy R, Johnson C, Kelley S, Hurwitz S, Travers J (1998) Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line J Biol Chem 273:18891–18897
Ishii S, Nagase T, Shimizu T (2002) Platelet-activating factor receptor. Prost Other Lipid Mediat 68:599–609
Kripke ML, Anathaswamy H (2003) Carcinogenesis: ultraviolet radiation. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) Dermatology in general Medicine. McGraw-Hill, New York, pp 797–804
Li T, Southall MD, Yi Q, Pei Y, Lewis D, Al-Hassani M, Spandau D, Travers JB (2003) The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines. J Biol Chem 278:16614–16621
Marathe G, Johnson C, Billings SD, Southall MD, Pei Y, Spandau D, Murphy RC, Zimmerman GA, McIntyre TM, Travers JB (2005) Ultraviolet B radiation generates PAF-like phospholipid mediators underlying cutaneous damage J Biol Chem 280:35448–35455
Marques SA, Dy L, Southall MD, Yi Q, Smietana E, Kapur R, Marques M, Travers JB, Spandau D (2002) The platelet-activating factor receptor activates the ERK MAP kinase and induces proliferation of epidermal cells through an EGF Receptor-dependent pathway. J Pharmacol Exp Therapeut 300:1026–1035
Papoutsaki M, Moretti F, Lanza M, Marinari B, Sartorelli V, Guerrini L, Chimenti S, Levrero M, Costanzo A (2005) A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes. Oncogene 24(46):6970–6975
Pei Y, Barber LA, Murphy RC, Johnson CA, Kelley SW, Dy LC, Fertel RH, Nguyen TM, Williams DA, Travers JB (1998) Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J Immunol 161: 1954–1961
Southall M, Isenberg J, Nakshatri H, Yi Q, Pei Y, Spandau D, Travers J (2001) The platelet-activating factor receptor protects epidermal cells from tumor necrosis factor (TNF) α and TNF-related apoptosis inducing ligand-induced apoptosis through an NF-кB-dependent process. J Biol Chem 276: 45548–45554
Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Lin Lab Sci 40(6):643–672
Travers J, Huff J, Rola-Plaeszczynski M, Gelfand E, Morelli J, Murphy R (1995) Identification of functional platelet-activating factor receptors on human keratinocytes. J Invest Dermatol 105:816–823
Walterscheid JP, Ullrich SE, Ngheim DX (2002) Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 195:171–179
Wolf P, Ngheim DX, Walterscheid JP, Byrne S, Matsumura Y, Matsumura Y, Bucana C, Ananthaswamy HN, Ullrich SE (2006) Platelet-activating factor (PAF) is crucial in psoralen + UVA (PUVA)-induced immune suppression, inflammation, and apoptosis. Am J Path 169(3):795–805
Acknowledgments
The authors wish to thank Drs. Raymond L. Konger and Dan Spandau for their advice in writing this paper. This research was supported in part by grants from the Riley Memorial Association, and the National Institutes of Health grants HL62996 and U19 AI070448 and Veteran’s Administration Merit Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Landis, M., Yi, Q., Hyatt, AM. et al. Involvement of P38 MAP kinase in the augmentation of UVB-mediated apoptosis via the epidermal platelet-activating factor receptor. Arch Dermatol Res 299, 263–266 (2007). https://doi.org/10.1007/s00403-007-0753-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-007-0753-x